Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Peter Lee is listed as Head of Rare Hematology Franchise and Head of Strategy & Planning, Rare Disease Business Unit, Japan Pharma Business Unit at Takeda, a with 32621 employees, based in Tokyo, Japan. AeroLeads shows a matched LinkedIn profile for Peter Lee.
Peter Lee previously worked as Head of Rare Hematology Franchise, Rare Disease Business Unit, Japan Pharma Business Unit at Takeda and Head of Strategy & Planning, Rare Disease Business Unit, Japan Pharma Business Unit at Takeda. Peter Lee holds Ph.D., Neuroscience from Loyola University Chicago Stritch School Of Medicine.
This section adds company-level context without repeating Peter Lee's masked contact details.
Review company-level records connected to Peter Lee before choosing the right outreach path.
Global biopharma people leader with experience in commercial franchise management, P&L management, strategy & planning, execution & operations, business development, and portfolio management in international and regional settings.Enterprise mindset with the learning agility to resolve ambiguous and complex issues collaboratively putting the team's and enterprise's interest first, with a thorough understanding of cross-functional interdependencies and the need for leadership communication for inclusive culture, growth mindset, and shared enterprise values.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Tokyo, Japan
• Lead marketing and sales of the Rare Hematology Franchise with a portfolio of in-market and new/launching brands, managing P&L, prioritization, and resource allocation• Nurture an inclusive and empowering environment for our people to achieve the franchise goals as a team
Tokyo, Japan
• Lead portfolio-level decision-making and business unit performance management while formulating and executing Japan rare disease business development strategy and search & evaluation, also providing support for BD operations and execution and for launch excellence for Japan commercial launch• Design digital and data-driven business strategy for supporting strategic initiatives for the Rare Disease BU and the broader Japan BU enterprise such as customer expansion, inside/outside sales activity optimization.
• Led strategy, business planning & operations, and leadership communication for global commercial franchises: co-led launch preparation for late-stage global assets
• Led out-licensing, divestiture, and in-licensing due diligence process and supported negotiation and contracting process for commercial and development stage assets in line with corporate and business development strategy
Greater Boston Area
• Responsible for supporting synergy strategy, new organization model implementation, systems harmonization, and governance process required to successfully integrate businesses, working closely with all Integration office teams and all 20+ functional teams across the enterprise
Greater Boston Area
• Portfolio management and business planning lead: integrated project plans, portfolio prioritization, asset attribute management, investor relations, annual CEO portfolio review; budget and long-range planning; governance management; supporting special strategic initiatives.
Greater Boston Area
• Global program, alliance, & portfolio management: led and executed strategy in solid tumor assets development: led the strategic decision-making process, cross-functional planning, execution, and operation, cross-organization strategic and financial planning.
Greater Boston Area
• Strategic advisory, global program management and development, market and risk Analysis for innovative assets, clinical and regulatory strategy development.
United States
• Innovation Advisory, Corporate Strategy, Project Management, Business Development, Strategic Prioritization, and International Development; Core regional strength: India, Korea, Israel, and other South/ East Asia
Other employees you can reach at takeda.com. View company contacts for 32621 employees →
Chantal Philipp
Colleague at TakedaHettingen, Baden-Württemberg, Germany
View →
KK
Kristine Krol
Colleague at TakedaThousand Oaks, California, United States
View →
LL
Lynda Libby
Colleague at TakedaGreater Boston, United States
View →
EC
Elisa Chan
Colleague at TakedaLos Angeles Metropolitan Area, United States
View →
GP
Glen Polley
Colleague at TakedaZurich, Switzerland
View →
JR
Julie Rivière-Lorphèvre
Colleague at TakedaCharleroi Metropolitan Area, Belgium
View →
BS
Bernhard Steiner
Colleague at TakedaEckartsau, Lower Austria, Austria
View →
JW
Jayme Whittington
Colleague at TakedaGreater Jackson Area, United States
View →
IW
Iwan Wibawa
Colleague at TakedaIndonesia
View →
KS
Katrin Schörgenhofer
Colleague at TakedaAustria
View →
Quick answers generated from the profile data available on this page.
Peter Lee works for Takeda.
Peter Lee is listed as Head of Rare Hematology Franchise and Head of Strategy & Planning, Rare Disease Business Unit, Japan Pharma Business Unit at Takeda.
Peter Lee is based in Tokyo, Japan while working with Takeda.
Peter Lee has worked for Takeda, Takeda Pharmaceuticals, Merrimack Pharmaceuticals, Halloran Consulting Group, Inc., and Sathguru Management Consultants.
Peter Lee's colleagues at Takeda include Chantal Philipp, Kristine Krol, Lynda Libby, Elisa Chan, and Glen Polley.
You can use AeroLeads to view verified contact signals for Peter Lee at Takeda, including work email, phone, and LinkedIn data when available.
Peter Lee holds Ph.D., Neuroscience from Loyola University Chicago Stritch School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Peter Lee you were looking for.
View similar profiles
